DCF — TRINITY HEALTH GRAND RAPIDS
Enterprise Value: $-532.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-532.2M
Enterprise Value
$-178.0M
PV of Cash Flows
$-354.2M
PV of Terminal Value
$-570.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $619.8M | $-27.9M | -5.0% | $-54.1M | $-49.2M |
| Year 2 | $638.4M | $-22.3M | -4.0% | $-49.4M | $-40.8M |
| Year 3 | $657.6M | $-16.4M | -3.0% | $-44.3M | $-33.3M |
| Year 4 | $677.3M | $-13.5M | -2.0% | $-42.2M | $-28.8M |
| Year 5 | $697.6M | $-12.2M | -2.0% | $-41.7M | $-25.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-532.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$601.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000000581603726
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5